COVID-19 Therapeutics and Treatment
Oral Antiviral
Paxlovid (Nirmatrelvir)
- Tarrytown Pharmacy is one of the pharmacies that has Paxlovid as an available COVID-19 treatment.
- Paxlovid is no longer supplied for free, meaning it now costs pharmacies money to purchase the medication.
- Tarrytown Pharmacy is one of the participating pharmacies in the Pfizer Paxcess program, which allows us to process manufacturer coupons and copay assistance.
- A prescription is required, pharmacists can no longer prescribe.
Paxlovid - The Process:
* Complete the form above to determine if you are eligible for treatment
* If you are NOT eligible, our form will let you know.
* If you ARE eligible, you will be able to book a COVID-19 Consultation. There is a non-refundable cost of $49.99 associated with the consult.
* Our pharmacist staff will review your request and then contact you via phone to confirm appropriateness of therapy, and then prescribe treatment (if appropriate)
WHAT IS A MONOCLONAL ANTIBODY?
Monoclonal antibodies (mAb) are a new treatment option for COVID-19 which has been given emergency use authorization (EUA) by the FDA. Monoclonal antibodies are designed in a laboratory to do what our own natural antibodies do, only better. Antibodies are what our body makes on its own to identify and fight infection. The reason we might require treatment with monoclonal antibodies, or mAbs, is that our body may not recognize this new virus SARS-Cov-2 which causes COVID-19. Treatment with mAbs requires direct administration to patients via IV infusion or injection under the skin (subcutaneously). When receiving treatment with mAbs, our bodies can very quickly recognize and fight COVID-19 infection. This is why mAb treatment may help recently exposed or infected patients who are at high risk for serious symptoms or having to stay in the hospital.
mAb treatment for COVID-19 is different from a COVID-19 vaccine. A vaccine causes your body’s natural immune response to turn on, but the process of asking your body to make antibodies or biological markers to identify a certain infection can take weeks. Some vaccines for COVID-19 require two shots, so your body can develop its own immune response to the disease, and these vaccines are highly effective. But if you already have the virus, mAb treatment quickly gives your body the antibodies it needs to protect itself. (1)
Improved
Evusheld
As of January 26th 2023, Evusheld is NO LONGER AUTHORIZED for use in the United States.
The FDA updated the Letter of Authorization for Evusheld, and it can no longer be used. The reason is that data shows Evusheld is unlikely to be active against more than 90% SARS-CoV-2 variants that are currently circulating.
Monoclonal Antibodies
COVID-19 Antibody Treatment (REGEN-COV™)
The FDA has removed this product from the market due to the lack of effectiveness against the Omicron variant.
This is no longer available any where in the country.
Works Cited
(1). Assistant Secretary for
Public Affairs (ASPA). “Monoclonal Antibodies for High-Risk COVID-19 Positive
Patients.” CombatCOVID.hhs.gov, 24 Aug. 2021,
https://combatcovid.hhs.gov/i-have-covid-19-now/monoclonal-antibodies-high-risk-covid-19-positive-patients.